Annexin A1: A new biomarker for predicting nasopharyngeal carcinoma response to radiotherapy

Medical Hypotheses

Volumn 81, Issue 1, 2013, Pages 68-70

  Zeng, Gu Qing ^a,b   Cheng, Ai Lan ^b   Tang, Jie ^c   Li, Guo Qing ^b   Li, Mei Xiang ^b   Qu, Jia Quan ^a   Cao, Chao ^a   Liao, Li ^b   Xiao, Zhi Qiang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF SOUTH CHINA   (China)

^c HUNAN CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; LIPOCORTIN 1;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CELL CYCLE PROGRESSION; CELL DEATH; CELL PROLIFERATION; DOWN REGULATION; HUMAN; IONIZING RADIATION; NASOPHARYNX CARCINOMA; PREDICTIVE VALUE; PROTEIN EXPRESSION; RADIOSENSITIVITY; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR CELL; TUMOR GROWTH; TUMOR RECURRENCE;

ANNEXIN A1; HUMANS; NASOPHARYNGEAL NEOPLASMS; RADIOTHERAPY; TUMOR MARKERS, BIOLOGICAL;

EID: 84878537506     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.04.019     Document Type: Article

References (30)

1. Ho J.H. An epidemiologic and clinical study of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1978, 4:182-198.
2. Feng X.P., Yi H., Li M.Y., et al. Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics. Cancer Res 2010, 70:3450-3462.
3. Teo P., Yu P., Lee W.Y., et al. Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. Int J Radiat Oncol Biol Phys 1996, 36:291-304.
4. DeNittis A.S., Liu L., Rosenthal D.I., Machtay M. Nasopharyngeal carcinoma treated with external radiotherapy, brachytherapy, and concurrent/adjuvant chemotherapy. Am J Clin Oncol 2002, 25:93-95.
5. Lee A.W., Poon Y.F., Foo W., et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 1992, 23:261-270.
6. Leung S.F., Teo P.M., Shiu W.W., Tsao S.Y., Leung T.W. Clinicalfeatures and management of distant metastases of nasopharyngeal carcinoma. J Otolaryngol 1991, 20:27-29.
7. Lim L.H., Pervaiz S. Annexin 1: the new face of an old molecule. FASEB J 2007, 21:968-975.
8. Tabe Y., Jin L., Contractor R., et al. Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of Annexin A1. Cell Death Differ 2007, 14(8):1443-1456.
9. Hsiang C.H., Tunoda T., Whang Y.E., Tyson D.R., Ornstein D.K. The impact of altered Annexin I protein levels on apoptosis and signal transduction pathways in prostate cancer cells. Prostate 2006, 66(13):1413-1424.
10. Ravi R., Bedi A. NF-kappaβ in cancer - a friend turned foe. Drug Resist Update 2004, 7(1):53-67.
11. Wang C.Y., Mayo M.W., Baldwin A.S. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaβ. Science 1996, 274(5288):784-787.
12. Wang C.Y., Cusack J.C., Liu R., Baldwin A.S. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaβ. Nat Med 1999, 5(4):412-417.
13. Guo Y., Zhu X.D., Qu S., et al. Identification of genes involved in radioresistance of nasopharyngeal carcinoma by integrating gene ontology and protein-protein interaction networks. Int J Oncol 2012, 40(1 (January)):85-92.
14. Kuo Y.C., Lin W.C., Chiang I.T., et al. Sorafenib sensitizes human colorectal carcinoma to radiation via suppression of NF-κβ expression in vitro and in vivo. Biomed Pharmacother 2012, 66(1):12-20.
15. Zhang Z., Huang L., Zhao W., Rigas B. Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaβ and inhibits its activation: anticancer effects in vitro and in vivo. Cancer Res 2010, 70(6):2379-2388.
16. Gudkov A.V., Komarova E.A. The role of p53 in determining sensitivity to radiotherapy. Nat Rev Cancer 2003, 3:117-129.
17. Friend S. p53: a glimpse at the puppet behind the shadow play. Science 1994, 265:334-335.
18. Bunz F., Dutriaux A., Lengauer C., et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998, 282:1497-1501.
19. Concin N., Stimpfl M., Zeillinger C., et al. Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines. Int J Oncol 2003, 22:51-57.
20. Zeng G.Q., Yi H., Li X.H., et al. Identification of the proteins related to p53-mediated radioresponse in nasopharyngeal carcinoma by proteomic analysis. J Proteomics 2011, 74(12):2723-2733.
21. Alldridge L.C., Bryant C.E. Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK1/2 MAPK signal. Exp Cell Res 2003, 290:93-107.
22. D'Acquisto F., Merghani A., Lecona E., et al. Annexin-1 modulates T-cell activation and differentiation. Blood 2007, 109(3):1095-1102.
23. Solito E., de Coupade C., Canaider S., Goulding N.J., Perretti M. Transfection of annexin 1 in monocytic cells produces a high degree of spontaneous and stimulated apoptosis associated with caspase-3 activation. Br J Pharmacol 2001, 133(2):217-228.
24. Lecona E., Barrasa J.I., Olmo N., Llorente B., Turnay J., Lizarbe M.A. Upregulation of Annexin A1 expression by butyrate in human colon adenocarcinoma cells: role of p53, NF-Y and p38 mitogen-activated protein kinase. Mol Cell Biol 2008, 28(15):4665-4674.
25. Tan S.X., Hu R.C., Dai A.G., Tang C.E., Yi H., Cheng A.L., et al. DNA methylation inhibits ANXA1 gene expression in nasopharyngeal carcinoma cell lines. Prog Biochem Biophys 2009, 36(10):1319-1326.
26. Rodrigo J.P., Garcia-Pedrero J.M., Fernandez M.P., Morgan R.O., Suárez C., Herrero A. Annexin A1 expression in nasopharyngeal carcinoma correlates with squamous differentiation. Am J Rhinol 2005, 19(5):483-487.
27. Cheng A.L., Huang W.G., Chen Z.C., et al. Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis. Clin Cancer Res 2008, 14(2):435-445.
28. Zhu F., Wang Y., Zeng S., Fu X., Wang L., Cao J. Involvement of Annexin A1 in multidrug resistance of K562/ADR cells identified by the proteomic study. OMICS 2009, 13(6):467-476.
29. Chuthapisith S., Bean B.E., Cowley G., et al. Annexins in human breast cancer: possible predictors of pathological response to neoadjuvant chemotherapy. Eur J Cancer 2009, 45(7):1274-1281.
30. Fan X., Krahling S., Smith D., Williamson P., Schlegel R.A. Macrophage surface expression of Annexins I and II in the phagocytosis of apoptotic lymphocytes. Mol Biol Cell 2004, 15:2863-2872.